The increased incidence over the past decade of bloodstream infections (BSIs) caused by gram-positive bacteria, particularly methicillin-resistant Staphylococcus aureus , highlights the critical need for a consistent approach to therapy. However, there is currently no international consensus on the diagnosis and management of gram-positive BSIs. The Clinical Consensus Conference on Gram-Positive Bloodstream Infections was convened as a session at the 9th International Symposium on Modern Concepts in Endocarditis and Cardiovascular Infections held in 2007. Participants discussed various aspects of the practical treatment of patients who present with gram-positive BSI, including therapeutic options for patients with BSIs of undefined origin, ...
OBJECTIVE: To evaluate the epidemiology, antibiotic susceptibility and clinical outcome of gram ne...
Background: In India, gram-positive infections (GPIs) particularly, methicillin-resistant Staphyloco...
This supplement is based on the proceedings of a Novartis-sponsored session at the 9th International...
The increased incidence over the past decade of bloodstream infections (BSIs) caused by gram-positiv...
Summary Background The treatment of severe bloodstream infections (sepsis, endocarditis, and infecti...
SummaryBackgroundThe treatment of severe bloodstream infections (sepsis, endocarditis, and infection...
Background: The treatment of severe bloodstream infections (sepsis, endocarditis, and infections of ...
Bloodstream infections (BSIs) are common, however international guidelines are available only for me...
Bloodstream infections (BSIs) are among the leading causes of morbidity and mortality worldwide, amo...
Objectives: To define standardized endpoints to aid the design of trials that compare antibiotic the...
European Congress of Clinical Microbiology and Infectious Diseases 2017 (22-25 April, Vienna, Austri...
Staphylococcus aureus is a common cause of severe bloodstream infection.We performed a systematic re...
OBJECTIVES: Although infectious disease (ID) consultation has been associated with lower mortality i...
Background: Multidrug resistance among gram-positive pathogens in tertiary and other care centers is...
Some of the most serious healthcare-associated infections (HAI) are highly deadly bloodstream infect...
OBJECTIVE: To evaluate the epidemiology, antibiotic susceptibility and clinical outcome of gram ne...
Background: In India, gram-positive infections (GPIs) particularly, methicillin-resistant Staphyloco...
This supplement is based on the proceedings of a Novartis-sponsored session at the 9th International...
The increased incidence over the past decade of bloodstream infections (BSIs) caused by gram-positiv...
Summary Background The treatment of severe bloodstream infections (sepsis, endocarditis, and infecti...
SummaryBackgroundThe treatment of severe bloodstream infections (sepsis, endocarditis, and infection...
Background: The treatment of severe bloodstream infections (sepsis, endocarditis, and infections of ...
Bloodstream infections (BSIs) are common, however international guidelines are available only for me...
Bloodstream infections (BSIs) are among the leading causes of morbidity and mortality worldwide, amo...
Objectives: To define standardized endpoints to aid the design of trials that compare antibiotic the...
European Congress of Clinical Microbiology and Infectious Diseases 2017 (22-25 April, Vienna, Austri...
Staphylococcus aureus is a common cause of severe bloodstream infection.We performed a systematic re...
OBJECTIVES: Although infectious disease (ID) consultation has been associated with lower mortality i...
Background: Multidrug resistance among gram-positive pathogens in tertiary and other care centers is...
Some of the most serious healthcare-associated infections (HAI) are highly deadly bloodstream infect...
OBJECTIVE: To evaluate the epidemiology, antibiotic susceptibility and clinical outcome of gram ne...
Background: In India, gram-positive infections (GPIs) particularly, methicillin-resistant Staphyloco...
This supplement is based on the proceedings of a Novartis-sponsored session at the 9th International...